Jeffrey Tyner, Ph.D.

Head Shot of Jeffrey Tyner
click here

Selected Publications

"Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia," Leukemia Research Reports (Vol: 3, Issue: 2, Page 67-69) - 2015

"Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia," Clinical Cancer Research (Vol: 20, Issue: 8, Page 2092-2103) - 2014

"Corepressor Rcor1 is essential for murine erythropoiesis," Blood (Vol: 123, Issue: 20, Page 3175-3184) - 2014

"Functional genomics for personalized cancer therapy," Science Translational Medicine (Vol: 6, Issue: 243, ) - 2014

"Functional integration of acute myeloid leukemia into the vascular niche," Leukemia - 2014



  Email Jeffrey Tyner

503 346-0603